S. 4303 · 117th Congress
Interchangeable Biologics Clarity Act
- Stage
- In committee
- Sponsor
- Tim Kaine
- Introduced
- 2022-05-25
- Latest action
- 2022-05-25 · Introduced in Senate
Summary
Interchangeable Biologics Clarity Act
This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.